These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1102116)

  • 1. Production and in vivo effect of antibodies against guinea pig lymphokines.
    Geczy CL; Friedrich W; de Weck AL
    Cell Immunol; 1975 Sep; 19(1):65-77. PubMed ID: 1102116
    [No Abstract]   [Full Text] [Related]  

  • 2. Migration inhibition and stimulation factors produced from peripheral blood lymphocyte cultures of sensitised guinea pigs.
    Matsui Y; Oshima S
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):151-5. PubMed ID: 3907650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of an antibody against guinea pig MIF. I. Specificity of the anti-MIF antibody.
    Onozaki K; Haga S; Miura K; Ichikawa M; Hashimoto T
    Cell Immunol; 1979 Dec; 48(2):258-66. PubMed ID: 389441
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the concentration of inducing agent on the output of lymphokines in the guinea pig.
    Ford WH; Ashworth LA; Inder S
    Eur J Immunol; 1976 Feb; 6(2):135-8. PubMed ID: 786697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of an antibody against guinea pig MIF. II. Analysis of the antibody-reacting material using radiolabeled lymphokines.
    Onozaki K; Haga S; Miura K; Homma Y; Hashimoto T
    Cell Immunol; 1980 Oct; 55(2):465-75. PubMed ID: 7000379
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activation of immune lymphocytes by antigenic stimulation in cell mediated immunity. I. Requirement for macrophages in antigen-induced MIF production by guinea pig immune lymphocytes in vitro.
    Ohishi M; Onoue K
    Cell Immunol; 1975 Jul; 18(1):220-32. PubMed ID: 806355
    [No Abstract]   [Full Text] [Related]  

  • 11. Production and characterization of antisera against guinea pig macrophage activating factor.
    Peck R; Talmadge K; Polak L
    Int Arch Allergy Appl Immunol; 1984; 75(4):361-7. PubMed ID: 6389371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphokine production in the cell-mediated immune response (author's transl)].
    Chou CS; Han SH
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Sep; 10(3):51-9. PubMed ID: 580234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of suppressor cells in the production of macrophage migration inhibition factor.
    Fox RA; Rajaraman K
    Immunol Commun; 1978; 7(3):311-21. PubMed ID: 350758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparsion of the properties of two antigen-induced guinea pig lymphokines.
    Ashworth LA; Eckersley BJ; Ford WH
    Int Arch Allergy Appl Immunol; 1975; 48(1):143-55. PubMed ID: 46849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin reaction, inhibition of macrophage migration, and lymphocyte transformation with tuberculin active peptide (TAP) and arabinogalactan obtained from tubercle bacilli.
    Niinaka T; Kishimoto S; Aoki T; Ikegami H; Ito F
    Int Arch Allergy Appl Immunol; 1975; 49(5):585-96. PubMed ID: 809364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of human lymphokines in vitro. Evidence for a migration stimulation factor (MStF) which interferes with the macrophage migration inhibition assay.
    Aaskov JG; Anthony HM
    Aust J Exp Biol Med Sci; 1976 Dec; 54(6):527-39. PubMed ID: 800335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of two lymphocyte chemotactic factors by antigen-stimulated guinea pig lymphocytes.
    Harita S; Shimokawa Y; Hayashi H
    Int Arch Allergy Appl Immunol; 1983; 70(2):118-23. PubMed ID: 6822438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antilymphocyte serum against lymphocytes of immunized rats on antibody formation to erythrocytes (guinea pig erythrocytes, human erythrocytes, primary response, secondary response).
    Hrubá A; Paluska E; Krecek M
    Folia Biol (Praha); 1972; 18(5):380-4. PubMed ID: 4636758
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte-derived factors affecting cell migration in vitro.
    Bergstrand H
    Allergy; 1979 Apr; 34(2):69-96. PubMed ID: 382903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.